Refresh

FDC LTD. - Company Received ANDA Approval For Ofloxacin Otic Solution, 0.3%.


Download
21 Jan 2022
This is to inform you that, the Company has been granted ANDA approval by United States Food and Drug Administration (U.S. FDA), for Ofloxacin Otic Solution, 0.3%. Kindly take the same on record.

Source: BSE India

View all announcements for FDC LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com